However, there are typical starting points that are generally recommended by doctors
The safety profile of AOD-9604 is favorable compared to many metabolic interventions, with clinical trials involving approximately 900 participants demonstrating good tolerability and minimal side effects
Langan RC, Zawistoski KJ (2011) Update on vitamin B12 deficiency
Rarely, some people may experience mild, short-term effects like: Redness or irritation at the injection site Temporary tiredness Headaches or nausea (rare) Unlike other weight loss drugs or hormonal therapies, AOD 9604 will not affect blood sugar, IGF-1, or organ growth, making it a safer long-term source of support for metabolism
Ethiop J Health Sci
Some patients require weekly injections initially, followed by maintenance doses every few months